0001209191-17-050810.txt : 20170830 0001209191-17-050810.hdr.sgml : 20170830 20170830190451 ACCESSION NUMBER: 0001209191-17-050810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170829 FILED AS OF DATE: 20170830 DATE AS OF CHANGE: 20170830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tanda Stephan B. CENTRAL INDEX KEY: 0001679516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37837 FILM NUMBER: 171061773 MAIL ADDRESS: STREET 1: C/O PATHEON N.V. STREET 2: HERENGRACHT 483 CITY: AMSTERDAM STATE: P7 ZIP: 1017 BT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Patheon N.V. CENTRAL INDEX KEY: 0001643848 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981153534 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN BUSINESS PHONE: 31 (20) 622-3243 MAIL ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN FORMER COMPANY: FORMER CONFORMED NAME: Patheon Holdings Cooperatief U.A. DATE OF NAME CHANGE: 20150601 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-29 1 0001643848 Patheon N.V. PTHN 0001679516 Tanda Stephan B. C/O PATHEON N.V. EVERT VAN DE BEEKSTRAAT 104 AMSTERDAM SCHIPHOL P7 1118 CN NETHERLANDS 1 0 0 0 Restricted Stock Units (Ordinary Shares) 2017-08-29 4 U 0 4659 35.00 D 0 D Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. This amount represents 4,659 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer. /s/ Eric M. Sherbet, Attorney-In-Fact 2017-08-30